Skip to content

Humira 40 mg solution for injection in pre-filled pen

DRUG6 trials

Sponsors

Abbvie Deutschland GmbH & Co. KG, Assistance Publique Hopitaux De Paris, Centre Hospitalier Universitaire De Saint Etienne, Diakonhjemmet Sykehus AS, University Of Medicine And Pharmacy Carol Davila Bucharest, Medical University Of Vienna, Karolinska University Hospital, IRCCS Istituto Giannina Gaslini

Conditions

Juvenile idiopathic arthritisRheumatoid ArthritisRheumatoid arthritisand pan-uveitisnoninfectious uveitisposteriorrecently active non-infectious intermediate

Phase 3

Phase 4

A multi-center, open, randomized, 18-month, parallel-group, superiority study to compare the effect of proactive therapeutic drug monitoring versus standard of care with regards to maintenance of sustained disease control without flare in adults with rheumatoid arthritis treated with a subcutaneous tumor necrosis factor inhibitor
RecruitingCTIS2023-510184-35-00
Diakonhjemmet Sykehus AS, University Of Medicine And Pharmacy Carol Davila Bucharest, Medical University Of Vienna, Karolinska University HospitalRheumatoid arthritis
Start: 2024-08-20Target: 410Updated: 2025-09-12
Toward personalized medicine to guide drug withdrawal in children with juvenile idiopathic arthritis in clinical remission: a randomized clinical trial comparing early versus late drug withdrawal combining imaging and multi-Omics.
RecruitingCTIS2024-514732-24-00
IRCCS Istituto Giannina GasliniJuvenile idiopathic arthritis
Start: 2025-04-28Target: 328Updated: 2025-08-26
Evaluation of a therapeutic de-eScalation strategy based on therapeutic drug MOnitOring in chronic non-infectious uveitis Treated witH adalimumab
Not yet recruitingCTIS2023-509733-39-00
Centre Hospitalier Universitaire De Saint Etiennenoninfectious uveitis
Target: 320Updated: 2025-04-28
DISCO-RA:DIScontinuation of COncomitant disease modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis patients also using TNF inhibitors - a randomized long-term non-inferiority strategy trial
Not yet recruitingCTIS2026-525316-33-00
Sint Maartenskliniek StichtingRheumatoid arthritis
Target: 202Updated: 2026-06-09